- Home
- Publications
- Publication Search
- Publication Details
Title
Aptamer-Driven Toxin Gene Delivery in U87 Model Glioblastoma Cells
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-16
DOI
10.3389/fphar.2021.588306
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aptamer-Conjugated Au Nanocage/SiO2 Core–Shell Bifunctional Nanoprobes with High Stability and Biocompatibility for Cellular SERS Imaging and Near-Infrared Photothermal Therapy
- (2019) Shengping Wen et al. ACS Sensors
- Enhancement of Radiosensitization by Silver Nanoparticles Functionalized with Polyethylene Glycol and Aptamer As1411 for Glioma Irradiation Therapy
- (2019) Jing Zhao et al. International Journal of Nanomedicine
- Targeted delivery of melittin to cancer cells by AS1411 anti-nucleolin aptamer
- (2018) Seyed Hossein Rajabnejad et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Targeted suicide gene transfections reveal promising results in nu/nu mice with aggressive neuroblastoma
- (2018) Simko Sama et al. JOURNAL OF CONTROLLED RELEASE
- Cancer-targeted photothermal therapy using aptamer-conjugated gold nanoparticles
- (2018) Eun Ji Hong et al. JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
- AS1411 aptamer conjugated gold nanoclusters as a targeted radiosensitizer for megavoltage radiation therapy of 4T1 breast cancer cells
- (2018) Fatemeh Ghahremani et al. RSC Advances
- Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins
- (2018) Francesco Giansanti et al. Toxins
- Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers
- (2018) Khalil Abnous et al. Expert Opinion on Drug Delivery
- T1–T2 molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents
- (2018) Jingjing Li et al. International Journal of Nanomedicine
- Local strategies and delivery systems for the treatment of malignant gliomas
- (2018) Feng Yu et al. JOURNAL OF DRUG TARGETING
- G-Quadruplex-Based Nanoscale Coordination Polymers to Modulate Tumor Hypoxia and Achieve Nuclear-Targeted Drug Delivery for Enhanced Photodynamic Therapy
- (2018) Yu Yang et al. NANO LETTERS
- Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives
- (2018) Carla Esposito et al. Genes
- Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections
- (2018) Kumari Asha et al. Journal of Clinical Medicine
- In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy
- (2017) Jafar Mosafer et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolin
- (2017) Anne-Chloé Dhez et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Precise glioblastoma targeting by AS1411 aptamer-functionalized poly ( l -γ-glutamylglutamine)–paclitaxel nanoconjugates
- (2017) Zimiao Luo et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy
- (2017) Ka Ming Pang et al. NUCLEIC ACIDS RESEARCH
- Temozolomide induces autophagy in primary and established glioblastoma cells in an EGFR independent manner
- (2017) Silvia Würstle et al. Oncology Letters
- Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells
- (2017) Letizia Polito et al. Toxins
- Plant Ribosome-Inactivating Proteins: Progesses, Challenges and Biotechnological Applications (and a Few Digressions)
- (2017) Maria Fabbrini et al. Toxins
- Construction and characterization of gelonin and saporin plasmids for toxic gene-based cancer therapy
- (2016) Kyoung Ah Min et al. ARCHIVES OF PHARMACAL RESEARCH
- Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo
- (2016) Seyed Mohammad Taghdisi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Optimization of construct design and fermentation strategy for the production of bioactive ATF-SAP, a saporin based anti-tumoral uPAR-targeted chimera
- (2016) Alfredo Errico Provenzano et al. Microbial Cell Factories
- Aptamer–Drug Conjugates
- (2015) Guizhi Zhu et al. BIOCONJUGATE CHEMISTRY
- Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation
- (2015) E. Merit Reyes-Reyes et al. Molecular Oncology
- AS1411-conjugated gold nanospheres and their potential for breast cancer therapy
- (2015) Mohammad T. Malik et al. Oncotarget
- Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model
- (2015) Elisabetta Benedetti et al. Oncotarget
- AS1411 Aptamer and Folic Acid Functionalized pH-Responsive ATRP Fabricated pPEGMA–PCL–pPEGMA Polymeric Nanoparticles for Targeted Drug Delivery in Cancer Therapy
- (2014) Shantanu V. Lale et al. BIOMACROMOLECULES
- Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles
- (2014) Huile Gao et al. JOURNAL OF DRUG TARGETING
- Synthesis of AS1411-Aptamer-Conjugated CdTe Quantum Dots with High Fluorescence Strength for Probe Labeling Tumor Cells
- (2014) Mona Alibolandi et al. JOURNAL OF FLUORESCENCE
- Aptamer-Targeted DNA Nanostructures for Therapeutic Delivery
- (2014) Phapanin Charoenphol et al. MOLECULAR PHARMACEUTICS
- Bevacizumab for glioblastoma: current indications, surgical implications, and future directions
- (2014) Brandyn A. Castro et al. Neurosurgical Focus
- Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
- (2014) Marina Koutsioumpa et al. Recent Patents on Anti-Cancer Drug Discovery
- Mechanism of Polyplex- and Lipoplex-Mediated Delivery of Nucleic Acids: Real-Time Visualization of Transient Membrane Destabilization without Endosomal Lysis
- (2013) Zia ur Rehman et al. ACS Nano
- A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
- (2013) Jonathan E. Rosenberg et al. INVESTIGATIONAL NEW DRUGS
- Nucleolin Targeting AS1411 Modified Protein Nanoparticle for Antitumor Drugs Delivery
- (2013) Jinhui Wu et al. MOLECULAR PHARMACEUTICS
- Aptamer imaging with Cu-64 labeled AS1411: Preliminary assessment in lung cancer
- (2013) Junling Li et al. NUCLEAR MEDICINE AND BIOLOGY
- Saporin-S6: A Useful Tool in Cancer Therapy
- (2013) Letizia Polito et al. Toxins
- In situ labeling and imaging of cellular protein via a bi-functional anticancer aptamer and its fluorescent ligand
- (2012) Jun Ai et al. ANALYTICA CHIMICA ACTA
- Cytoplasmic vacuolization during exposure to drugs and other substances
- (2012) Toshihiko Aki et al. CELL BIOLOGY AND TOXICOLOGY
- Photosensitizer-incorporated G-quadruplex DNA-functionalized magnetofluorescent nanoparticles for targeted magnetic resonance/fluorescence multimodal imaging and subsequent photodynamic therapy of cancer
- (2012) Meili Yin et al. CHEMICAL COMMUNICATIONS
- Synthesis and Evaluation of Indole-Based Chalcones as Inducers of Methuosis, a Novel Type of Nonapoptotic Cell Death
- (2012) Michael W. Robinson et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Possible “Proton Sponge ” Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH
- (2012) Rikke V Benjaminsen et al. MOLECULAR THERAPY
- Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II
- (2011) Viviane Brel et al. BIOCHEMICAL PHARMACOLOGY
- A graphene functionalized electrochemical aptasensor for selective label-free detection of cancer cells
- (2011) Lingyan Feng et al. BIOMATERIALS
- Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates
- (2011) D. J. FitzGerald et al. CANCER RESEARCH
- Gene Therapy and Targeted Toxins for Glioma
- (2011) Maria G. Castro et al. CURRENT GENE THERAPY
- Glycosilated nucleolin as marker for human gliomas
- (2011) R. Galzio et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Evaluation of a bispecific biological drug designed to simultaneously target glioblastoma and its neovasculature in the brain
- (2011) Seunguk Oh et al. JOURNAL OF NEUROSURGERY
- Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy
- (2011) Letizia Polito et al. Toxins
- Parallel G-Quadruplex-Specific Fluorescent Probe for Monitoring DNA Structural Changes and Label-Free Detection of Potassium Ion
- (2010) Tao Li et al. ANALYTICAL CHEMISTRY
- Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization
- (2010) Ara G. Hovanessian et al. PLoS One
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Pichia pastoris as a host for secretion of toxic saporin chimeras
- (2009) Alessio Lombardi et al. FASEB JOURNAL
- Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
- (2009) S. Soundararajan et al. MOLECULAR PHARMACOLOGY
- Engineering a switchable toxin: the potential use of PDZ domains in the expression, targeting and activation of modified saporin variants
- (2009) F. Giansanti et al. PROTEIN ENGINEERING DESIGN & SELECTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search